Ranger Investment Management L.P. Sells 8,350 Shares of HealthEquity, Inc. $HQY

Ranger Investment Management L.P. lessened its position in HealthEquity, Inc. (NASDAQ:HQY) by 3.0% during the 3rd quarter, according to the company in its most recent Form 13F filing with the SEC. The institutional investor owned 274,130 shares of the company’s stock after selling 8,350 shares during the period. HealthEquity comprises 1.8% of Ranger Investment Management L.P.’s portfolio, making the stock its 23rd largest holding. Ranger Investment Management L.P. owned about 0.32% of HealthEquity worth $25,979,000 at the end of the most recent reporting period.

A number of other hedge funds also recently added to or reduced their stakes in the company. Norges Bank bought a new stake in shares of HealthEquity in the 2nd quarter worth $75,072,000. Westfield Capital Management Co. LP increased its holdings in HealthEquity by 124.6% in the 2nd quarter. Westfield Capital Management Co. LP now owns 1,265,208 shares of the company’s stock worth $132,543,000 after buying an additional 701,819 shares in the last quarter. AQR Capital Management LLC increased its holdings in HealthEquity by 148.5% in the 2nd quarter. AQR Capital Management LLC now owns 1,107,448 shares of the company’s stock worth $116,016,000 after buying an additional 661,795 shares in the last quarter. Man Group plc raised its position in HealthEquity by 1,331.8% in the 2nd quarter. Man Group plc now owns 254,652 shares of the company’s stock worth $26,677,000 after buying an additional 236,867 shares during the last quarter. Finally, Viking Global Investors LP bought a new position in HealthEquity during the 2nd quarter valued at about $23,021,000. 99.55% of the stock is currently owned by hedge funds and other institutional investors.

Analyst Ratings Changes

Several research analysts have recently weighed in on HQY shares. Citizens Jmp boosted their price objective on shares of HealthEquity from $117.00 to $122.00 and gave the company a “market outperform” rating in a report on Thursday, December 4th. Barrington Research reissued an “outperform” rating and set a $125.00 price target on shares of HealthEquity in a report on Thursday, December 4th. JPMorgan Chase & Co. lifted their price objective on HealthEquity from $126.00 to $129.00 and gave the stock an “overweight” rating in a report on Thursday, December 4th. KeyCorp upped their price objective on HealthEquity from $120.00 to $125.00 and gave the company an “overweight” rating in a research report on Thursday, January 8th. Finally, Weiss Ratings reaffirmed a “hold (c+)” rating on shares of HealthEquity in a research report on Thursday, January 22nd. Two investment analysts have rated the stock with a Strong Buy rating, twelve have assigned a Buy rating, two have assigned a Hold rating and one has assigned a Sell rating to the company. According to MarketBeat, HealthEquity currently has a consensus rating of “Moderate Buy” and a consensus price target of $119.60.

HealthEquity Stock Down 2.1%

HQY opened at $79.66 on Friday. The stock has a market cap of $6.81 billion, a price-to-earnings ratio of 36.54, a price-to-earnings-growth ratio of 1.01 and a beta of 0.24. The company has a debt-to-equity ratio of 0.46, a quick ratio of 4.13 and a current ratio of 4.13. The firm’s fifty day moving average is $91.06 and its 200 day moving average is $93.11. HealthEquity, Inc. has a fifty-two week low of $74.07 and a fifty-two week high of $116.65.

HealthEquity (NASDAQ:HQY) last released its earnings results on Wednesday, December 3rd. The company reported $1.01 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.90 by $0.11. HealthEquity had a return on equity of 12.94% and a net margin of 14.86%.The firm had revenue of $322.16 million during the quarter, compared to analysts’ expectations of $320.92 million. During the same quarter last year, the business posted $0.78 earnings per share. The firm’s revenue was up 7.2% on a year-over-year basis. HealthEquity has set its FY 2026 guidance at 3.870-3.950 EPS. On average, sell-side analysts forecast that HealthEquity, Inc. will post 2.32 earnings per share for the current fiscal year.

Insider Buying and Selling at HealthEquity

In other HealthEquity news, EVP Elimelech Rosner sold 10,959 shares of HealthEquity stock in a transaction on Thursday, December 18th. The shares were sold at an average price of $95.45, for a total value of $1,046,036.55. Following the sale, the executive vice president directly owned 45,742 shares in the company, valued at approximately $4,366,073.90. The trade was a 19.33% decrease in their position. The sale was disclosed in a legal filing with the SEC, which is accessible through this link. Also, EVP Delano Ladd sold 1,500 shares of the firm’s stock in a transaction dated Friday, December 19th. The shares were sold at an average price of $94.72, for a total value of $142,080.00. Following the transaction, the executive vice president owned 73,979 shares of the company’s stock, valued at approximately $7,007,290.88. The trade was a 1.99% decrease in their position. The disclosure for this sale is available in the SEC filing. Insiders have sold 13,959 shares of company stock valued at $1,344,957 over the last ninety days. 1.50% of the stock is currently owned by corporate insiders.

About HealthEquity

HealthEquity, Inc (NASDAQ: HQY) is a leading administrator of consumer-directed health accounts and related benefit solutions in the United States. Founded in 2002 and headquartered in Draper, Utah, the company specializes in health savings accounts (HSAs) and offers complementary services such as flexible spending accounts (FSAs), health reimbursement arrangements (HRAs), COBRA administration and commuter benefits. Through its technology-driven platform, HealthEquity enables employers, health plans and individuals to streamline account management, improve cost transparency and encourage more informed healthcare spending.

Serving millions of members across all 50 states, HealthEquity leverages an open-architecture ecosystem that integrates with health plans, payroll providers and financial institutions.